ABSTRACT
Informed consent should be seen as an essential part of health care practice; parental permission and childhood assent is an active process that engages patients, both adults and children, in their health care. Pediatric practice is unique in that developmental maturation allows, over time, for increasing inclusion of the child's and adolescent's opinion in medical decision-making in clinical practice and research. This technical report, which accompanies the policy statement "Informed Consent in Decision-Making in Pediatric Practice" was written to provide a broader background on the nature of informed consent, surrogate decision-making in pediatric practice, information on child and adolescent decision-making, and special issues in adolescent informed consent, assent, and refusal. It is anticipated that this information will help provide support for the recommendations included in the policy statement.
Subject(s)
Clinical Decision-Making , Informed Consent , Pediatrics , Adolescent , Child , Humans , Informed Consent/standards , Third-Party ConsentABSTRACT
BACKGROUND/PURPOSE: The aim of this study was to review evidence-based literature addressing pertinent questions about venous thromboembolism (VTE) after traumatic injury in children. METHODS: Data were obtained from English-language articles identified through Pubmed published from 1995 until November 2012, and from bibliographies of relevant articles. Studies were included if they contributed evidence to one of the following questions. In the pediatric traumatic injury population: (1) What is the overall incidence of VTE? (2) Is age (adolescence versus pre-adolescence) associated with higher VTE incidence? (3) Which risk factors are associated with higher VTE incidence? (4) Does mechanical and/or pharmacological prophylaxis impact outcomes? RESULTS: Eighteen articles were included in this systematic review. The evidence regarding each question was evaluated, graded by author consensus, and summarized. CONCLUSIONS: The overall incidence of VTE is low. Older (>13years) and more severely injured patients are at higher VTE risk. Additional factors including injury type or presence of a central venous catheter also place a patient at higher VTE risk. Implementation of a risk-based clinical practice guideline for VTE prophylaxis has been associated with reduced symptomatic VTE at one institution. Randomized, prospective trials analyzing outcomes of VTE prophylaxis in pediatric trauma victims are needed.
Subject(s)
Fibrinolytic Agents/therapeutic use , Intermittent Pneumatic Compression Devices , Venous Thromboembolism/prevention & control , Wounds and Injuries/complications , Adolescent , Age Factors , Catheterization, Central Venous/adverse effects , Child , Combined Modality Therapy , Humans , Incidence , Injury Severity Score , Risk Factors , Treatment Outcome , Venous Thromboembolism/epidemiology , Venous Thromboembolism/etiology , Wounds and Injuries/therapyABSTRACT
OBJECTIVE: To determine the success rate and complications of using the external jugular (EJ) vein for central venous access in pediatric patients. METHODS: Prospective cohort study of children who underwent attempts at EJ vein central venous access while receiving care in an 11-bed pediatric intensive care unit at an urban children's hospital. RESULTS: Over a period of 15 months, 50 patients had EJ venous cannulation attempts. Central venous access was achieved in 45 patients (90%). Successful central venous access was performed in 4 children (50%) younger than 1 year and in 36 older children (98%). Catheter-tip malposition on chest radiograph required subsequent line manipulation in 2 patients. No complications of pneumothorax or carotid artery puncture occurred during line insertion. The catheters were used for an average of 7.5 days (range, 1-28 days). Catheter malfunction occurred in 4 (1.21/100 catheter-days), and catheter-related bloodstream infections occurred in 2 patients (6.04/1000 catheter-days). No thrombotic complications were clinically detected. CONCLUSIONS: The EJ vein is a viable site for central venous access with a low complication rate in pediatric patients.
Subject(s)
Catheterization, Central Venous/methods , Critical Illness/therapy , Jugular Veins , Adolescent , Child , Child, Preschool , Follow-Up Studies , Hospitals, Urban , Humans , Infant , Infant, Newborn , Intensive Care Units, Pediatric , Prospective Studies , Treatment Outcome , Young AdultABSTRACT
Initial therapy of the poisoned child should follow the basic principles of advanced life support and include support of a patent airway and adequate oxygenation, ventilation, and circulation. Ingestion of certain substances require agent-specific therapy which may modify the standard resuscitative approach. Children can present following unknown or unsuspected ingestions. Any child with unexplained altered level of consciousness, respiratory, circulatory derangement, seizures or metabolic abnormalities should be considered for toxic ingestion. Knowing the typical signs and symptoms of the common toxic syndromes can help identification of the unknown ingestion. Recommendations for decontamination, detoxification, and antidotal therapies have changed over the past 10 years. Clinicians should be aware of the community resources available to help guide the evaluation and management of the poisoned child.
